文献速递神经肿瘤

基于甲基化谱的21 000例中枢神经系统肿瘤年龄分布分析:聚焦青少年和年轻成人

CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults.
PubMed 文献 · Neuro Oncol · 2026-01-01

本研究对21 712例经DNA甲基化谱分类的中枢神经系统肿瘤进行分析,其中5 351例(25%)来自15-39岁青少年和年轻成人(AYA)。AYA人群肿瘤类型呈混合模式,兼具儿童常见类型(如髓母细胞瘤)和成人常见类型(如胶质母细胞瘤),并识别出多种在AYA中富集的肿瘤类型、甲基化亚类及年龄相关基因组变异模式。

要点

  • AYA人群CNS肿瘤兼具儿童与成人类型,IDH突变型星形细胞瘤、多形性黄色星形细胞瘤等在AYA中富集。
  • DNA甲基化谱可识别AYA特异的肿瘤亚类及年龄相关基因组变异分布。
  • 该数据为AYA神经肿瘤的精准诊断和研究提供参考资源。

核心结论

  • 大规模甲基化谱分析揭示了AYA人群CNS肿瘤独特的分类模式,特定肿瘤类型、亚类和基因组变异在该人群中富集。

研究设计与样本

  • 研究纳入21 712例具有年龄标注且甲基化谱经NCI/Bethesda分类器高置信度匹配至CNS肿瘤类型的样本,其中AYA(15-39岁)肿瘤5 351例(25%)。

主要发现

  • AYA肿瘤呈现儿童型(如髓母细胞瘤)与成人型(如胶质母细胞瘤)混合模式。
  • 在AYA中富集的肿瘤类型包括IDH突变型星形细胞瘤、多形性黄色星形细胞瘤、后颅窝B组室管膜瘤和弥漫性半球胶质瘤H3 G34突变型等。
  • 多种肿瘤类型在AYA中观察到独特的甲基化亚类,基因组变异模式呈年龄特异性分布。

临床怎么用

  • 研究结果可作为参考资源,支持对AYA患者进行更精准、考虑年龄因素的诊断和神经肿瘤学研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Approximately 12 000 adolescents and young adults (ages 15-39, AYAs) are diagnosed with a primary central nervous system (CNS) tumor each year. DNA methylation profiling has transformed CNS tumor classification by refining diagnostic accuracy and identifying biologically distinct subtypes, but its application has not been systematically evaluated in the AYA population. In this study, we examined the spectrum of CNS tumor types across age groups, with a focus on the AYA population. METHODS: We assembled a large dataset of CNS tumor samples with age annotations and methylation profiles matching with high confidence to a CNS tumor type using the NCI/Bethesda classifier. Prevalence of tumor type, methylation class and DNA copy number aberrations were compared across age strata (pediatric, AYA, and adult). RESULTS: The cohort of 21 712 CNS tumors included 5351 tumors from AYAs (25%), which showed a mixed pattern, with tumors typical of childhood (eg, medulloblastoma) as well as those common in older adults (eg, glioblastoma). Several tumor types were specifically enriched in the AYA, including IDH-mutant astrocytoma, pleomorphic xanthoastrocytoma, posterior fossa group B ependymoma, and diffuse hemispheric glioma, H3 G34-mutant, among others. Distinct methylation subclasses of multiple tumor types were observed in the AYA, and patterns of genomic aberrations showed age-specific distributions. CONCLUSION: Large-scale methylation profiling revealed unique classification patterns of CNS tumors in AYAs, with specific tumor types, subclasses, and genomic alterations enriched in this population. These data may serve as a valuable reference resource for better understanding the spectrum of CNS tumors affecting AYA patients. Adolescents and young adults (ages 15-39) with brain tumors are often overlooked between “pediatric” and “adult” care, and accurate diagnosis can be challenging. In this study, we analyzed 21 712 CNS tumors classified using DNA methylation profiling, including 5351 tumors from AYA patients. We show that AYAs have a distinct mix of pediatric- and adult-type tumors, with several tumor entities and molecular subtypes especially enriched in this age group. We also identify age-related genomic patterns within tumor types. These findings provide a reference resource to support more precise, age-aware diagnosis and research in AYA neuro-oncology.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Fonseca A, Yefet L, Singh O, et al. CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults. Neuro Oncol. 2026. PMID: 41978543. doi:10.1093/neuonc/noag082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。